DeepLBCEPred

DeepLBCEPred predicts linear B-cell epitopes (BCEs) from antigen amino acid sequences to support immune recognition studies, vaccine development, and therapeutic antibody design.

Key Features:

• Bi-LSTM Networks: Capture bidirectional sequential dependencies in amino acid sequences to model contextual information from both upstream and downstream residues.
• Feed-Forward Attention Mechanism: Weight and emphasize relevant sequence positions to highlight critical epitope regions during prediction.
• Multi-Scale CNNs: Extract hierarchical local and global sequence features at multiple scales to detect diverse motif patterns.
• Integrated Deep Learning Architecture: Combine Bi-LSTM, feed-forward attention, and multi-scale CNNs to leverage complementary strengths for improved BCE prediction.
• Evaluation and Validation: Performance assessed via cross-validation on training datasets and independent testing on two separate testing datasets, demonstrating state-of-the-art performance versus existing computational methods.
• Component Contribution Analysis: Investigate the roles of individual deep learning elements in recognizing linear BCEs.

Scientific Applications:

• Epitope Mapping: Identify linear BCEs to inform antigen–antibody interaction studies.
• Vaccine Development: Prioritize candidate linear epitopes for vaccine antigen design.
• Therapeutic Antibody Design: Guide selection of antibody-targeted linear epitopes for therapeutic discovery.
• Immune Response Studies: Support analysis of immune recognition and response targeting linear epitopes.

Methodology:

Integrate bi-directional long short-term memory (Bi-LSTM) networks, a feed-forward attention mechanism, and multi-scale convolutional neural networks (CNNs); evaluate using cross-validation on training datasets and independent tests on two testing datasets; analyze contributions of each deep learning component.